simdax 2.5 mgml
bio-med - j.r ltd, israel - levosimendan - concentrate for solution for infusion - levosimendan 2.5 mg/ml - levosimendan - levosimendan - therapeutic indications: short-term treatment of acutely decompensated severe chronic heart failure.simdax should only be used as add-on therapy in situations where conventional therapy with e.g. diuretics, ace-inhibitors and digitalis is not sufficient and where there is a need for inotropic support.
simdax concentrate for solution for infusion
orion corporation - levosimendan - concentrate for solution for infusion - 2,5mg/ml
levosimendan 2.5 mg/ml concentrate for solution for infusion
as kalceks - levosimendan - concentrate for solution for infusion - levosimendan
simdax 2.5 mg/ml inf. sol. (conc.) i.v. vial
orion corp. - levosimendan 2,5 mg/ml - concentrate for solution for infusion - 2,5 mg/ml - levosimendan 2.5 mg/ml - levosimendan
levosimendan altan 2.5 mg/ml inf. sol. (conc.) i.v. vial
altan pharma ltd. - levosimendan 2,5 mg/ml - concentrate for solution for infusion - 2,5 mg/ml - levosimendan 2.5 mg/ml - levosimendan
simdax 2.5 mg/ml
شركة مستودع أدوية أوتار - awtar pharmaceutical co - levosimendan 2.5 mg/ml - 2.5 mg/ml
levosimendan kabi 2.5 mg/ml inf. sol. (conc.) i.v. vial
fresenius kabi sa-nv - levosimendan 2,5 mg/ml - concentrate for solution for infusion - 2,5 mg/ml - levosimendan 2.5 mg/ml - levosimendan
levosimendan kalceks 2.5 mg/ml inf. sol. (conc.) i.v. vial
as kalceks a.s. - levosimendan 2,5 mg/ml - concentrate for solution for infusion - 2,5 mg/ml - levosimendan 2.5 mg/ml - levosimendan
simdax 2.5 mg/ml inf. sol. (conc.) i.v. vial
orion corp. - levosimendan 2,5 mg/ml - concentrate for solution for infusion - levosimendan
simdax concentrate for solution for infusion
orion corporation - levosimendan - concentrate for solution for infusion - 2,5mg/ml